Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report

Authors

  • Shintaro Takeoka
  • Masahiro Kamata Department of Dermatology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605, Japan
  • Ikumi Yokoi
  • Aya Takehara
  • Yayoi Tada

DOI:

https://doi.org/10.2340/actadv.v101.545

Keywords:

atopic dermatitis, vitiligo vulgaris, dupilumab, interleukin-4, interleukin-13

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 2016; 375: 2335-2348.

https://doi.org/10.1056/NEJMoa1610020 DOI: https://doi.org/10.1056/NEJMoa1610020

Uchida H, Kamata M, Mizukawa I, Watanabe A, Agematsu A, Nagata M, et al. Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study. Br J Dermatol 2019; 181: 1083-1085.

https://doi.org/10.1111/bjd.18163 DOI: https://doi.org/10.1111/bjd.18163

Uchida H, Kamata M, Kato A, Mizukawa I, Watanabe A, Agematsu A, et al. One-year real-world clinical effectiveness, safety, and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: a single-center retrospective study. J Am Acad Dermatol 2021; 84: 547-550.

https://doi.org/10.1016/j.jaad.2020.05.102 DOI: https://doi.org/10.1016/j.jaad.2020.05.102

Wańkowicz-Kalińska A, van den Wijngaard RM, Tigges BJ, Westerhof W, Ogg GS, Cerundolo V, et al. Immunopolarization of CD4+ and CD8+ T cells to type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest 2003; 83: 683-695.

https://doi.org/10.1097/01.LAB.0000069521.42488.1B DOI: https://doi.org/10.1097/01.LAB.0000069521.42488.1B

Yang L, Wei Y, Sun Y, Shi W, Yang J, Zhu L, et al. Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes: a pivotal role of CD8+ cytotoxic t lymphocytes in vitiligo. Acta Derm Venereol 2015; 95: 664-670.

https://doi.org/10.2340/00015555-2080 DOI: https://doi.org/10.2340/00015555-2080

Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang SC, Marquardt N, et al. CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin. Immunity 2017; 46: 287-300.

https://doi.org/10.1016/j.immuni.2017.01.009 DOI: https://doi.org/10.1016/j.immuni.2017.01.009

Kanda N, Koto M, Hoashi T, Saeki H. Case of alopecia areata during dupilumab treatment for atopic dermatitis. J Dermatol 2019; 46: e332-e333.

https://doi.org/10.1111/1346-8138.14880 DOI: https://doi.org/10.1111/1346-8138.14880

Maloney NJ, Worswick S, Cheng K. Development of alopecia in patients treated with dupilumab. Dermatol Ther 2019; 32: e12869.

https://doi.org/10.1111/dth.12869 DOI: https://doi.org/10.1111/dth.12869

Ständer S, Trense Y, Thaçi D, Ludwig RJ. Alopecia areata development in atopic dermatitis patients treated with dupilumab. J Eur Acad Dermatol Venereol 2020; 34: e612-e613.

https://doi.org/10.1111/jdv.16493 DOI: https://doi.org/10.1111/jdv.16493

Ito T, Kageyama R, Nakazawa S, Honda T. Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata. Exp Dermatol 2020; 29: 726-732.

https://doi.org/10.1111/exd.14129 DOI: https://doi.org/10.1111/exd.14129

Downloads

Published

2021-10-28

How to Cite

Takeoka, S., Kamata, M., Yokoi, I., Takehara, A., & Tada, Y. (2021). Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report. Acta Dermato-Venereologica, 101(10), adv00581. https://doi.org/10.2340/actadv.v101.545